Telos Labs Acquires Flourish Fi

Aquiline to Invest in Flourish, a Wealthtech Platform for Independent Advisors

September 2, 2026

Financial Services

Aquiline entered into a definitive agreement to invest in Flourish, a wealthtech platform owned by MassMutual that provides private-bank-like solutions for Registered Investment Advisors (RIAs). The transaction is expected to close in Q4 2026, with Aquiline acquiring a controlling interest while MassMutual retains a significant stake.

Flourish Research Invests in Valkyrie Clinical Trials

October 6, 2025

Healthcare Services

Flourish Research, a Genstar Capital-backed multi-site clinical trial organization, has made a strategic investment in Valkyrie Clinical Trials to establish a meaningful presence in oncology. Valkyrie, founded by Dr. David Berz and operating three sites in Los Angeles, will leverage Flourish's national network and infrastructure to accelerate oncology trial access and patient recruitment.

Flourish to Acquire Sora Finance to Build Comprehensive Deposits and Lending Platform for RIAs

March 20, 2025

Payments & Fintech

Flourish, a technology platform for registered investment advisors (RIAs), entered into a definitive agreement to acquire Sora Finance, an AI-driven liability optimization platform for advisors. The combined offering is intended to provide RIAs with integrated asset and liability management, including cash management plus lending capabilities.

Flourish Research Acquires Diablo Clinical Research

February 18, 2025

Healthcare Services

Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina, has acquired Diablo Clinical Research, a Walnut Creek, California-based clinical research facility established in 1995 that has conducted more than 1,000 phase I–IV trials and medical device studies. The add-on acquisition (Flourish is PE-backed by Genstar Capital) expands Flourish's geographic footprint and therapeutic-area capabilities, particularly in endocrinology, cardiovascular and metabolic research.

Flourish Research (NMS Capital-backed) Acquires Valley Clinical Trials

September 15, 2023

Healthcare Services

NMS Capital–backed Flourish Research has acquired Valley Clinical Trials, a three-site clinical research organization in Los Angeles County focused on cardiology, metabolic and related therapeutic areas. The deal — Flourish’s ninth acquisition since 2021 — expands the platform’s West Coast footprint; terms were not disclosed and Valley’s founder and management will remain in their roles.

Brightflow AI Acquires CircleUp

June 2, 2023

Data & Analytics

Brightflow AI has acquired CircleUp, adding CircleUp's Helio data and machine-learning insights to Brightflow's financial intelligence platform. The deal will integrate CircleUp's consumer market analytics with Brightflow AI's cash-flow and financial forecasting tools to create a broader offering for consumer and e-commerce businesses; terms were not disclosed.